Using trained dogs and organic semi-conducting sensors to identify asymptomatic and mild SARS-CoV-2 infections: an observational study

Claire Guest, Sarah Y Dewhirst, Steve W Lindsay, David J Allen, Sophie Aziz, Oliver Baerenbold, John Bradley, Unnati Chabildas, Vanessa Chen-Hussey, Samuel Clifford, Luke Cottis, Jessica Dennehy, Erin Foley, Salvador A Gezan, Tim Gibson, Courtenay K Greaves, Immo Kleinschmidt, Sébastien Lambert, Anna Last, Steve Morant, Josephine E A Parker, John Pickett, Billy J Quilty, Ann Rooney, Manil Shah, Mark Somerville, Chelci Squires, Martin Walker, James G Logan, COVID Dogs Research Team, Robert Jones, Ana Assis, Ewan Borthwick, Laura Caton, Rachel Edwards, Janette Heal, David Hill, Nazifa Jahan, Cecelia Johnson, Angela Kaye, Emily Kirkpatrick, Sarah Kisha, Zaena Ledeatte Williams, Robert Moar, Tolulope Owonibi, Benjamin Purcell, Christopher Rixson, Freya Spencer, Anastasios Stefanidis, Sophie Stewart, Scott Tytheridge, Sian Wakley, Shanice Wildman, Catherine Aziz, Helen Care, Emily Curtis, Claire Dowse, Alan Makepeace, Sally-Anne Oultram, Jayde Smith, Fiona Shenton, Harry Hutchins, Robert Mart, Jo-Anne Cartwright, Miranda Forsey, Kerry Goodsell, Lauren Kittridge, Anne Nicholson, Angelo Ramos, Joanne Ritches, Niranjan Setty, Mark Vertue, Malin Bergstrom, Zain Chaudhary, Angus De Wilton, Kate Gaskell, Catherine Houlihan, Imogen Jones, Marios Margaritis, Patricia Miralhes, Leah Owens, Tommy Rampling, Hannah Rickman, Marta Boffito, Candida Fernandez, Bryony Cotterell, Anne-Marie Guerdette, George Tsaknis, Margaret Turns, Joanne Walsh, Lisa Frankland, Raha West, Maureen Holland, Natalie Keenan, Helen Wassall, Megan Young, Jade Rangeley, Gwendolyn Saalmink, Sanjay Adlakha, Philip Buckley, Lynne Allsop, Susan Smith, Donna Sowter, Alison Campbell, Julie Jones, Steve Laird, Sarah O'Toole, Courteney Ryan, Jessica Evans, James Rand, Natasha Schumacher, Tracey Hazelton, Andrew Dodgson, Susannah Glasgow, Denise Kadiu, Orianne Lopuszansky, Anu Oommen, Joshi Prabhu, Molly Pursell, Jane Turner, Hollie Walton, Robert Andrews, Irena Cruickshank, Catherine Thompson, Tania Wainwright, Alun Roebuck, Tara Lawrence, Kimberley Netherton, Claire Hewitt, Sarah Shephardson, Winston Andrew Crasto, Judith Lake, Rosemary Musanhu, Rebecca Walker, Karen Burns, Andrew Higham, Julie Le Bas, Nicola Mackenzie, Hilary Thatcher, Shannen Beadle, Sarah Buckley, Gail Castle, Aimee Fletcher, Sara Holbrook, Patricia Kane, Kate Lindley, Tracey Lowry, Stephanie Lupton, Sharon Oddy, Lynda Slater, Martin Sylvester, Kenneth Agwuh, Veronica Maxwell, Stephen Ryder, Kirsty Topham, Obi Egbuniwe, Rebecca Matthews, Alejandro Arenas-Pinto, Paulina Prymas, Abigail Severn, Amber Shaw, Safia Begum, Daniel Lenton, James Scriven, Lucy Leeman, Karen Rudge, Emma Storr, Ana Alvarez, Kate Forster, Daniel Hind, Natalie Cook, Rosanna Peeling, Peter Carey, Anne Wilson, Jane Davis, Claire Guest, Sarah Y Dewhirst, Steve W Lindsay, David J Allen, Sophie Aziz, Oliver Baerenbold, John Bradley, Unnati Chabildas, Vanessa Chen-Hussey, Samuel Clifford, Luke Cottis, Jessica Dennehy, Erin Foley, Salvador A Gezan, Tim Gibson, Courtenay K Greaves, Immo Kleinschmidt, Sébastien Lambert, Anna Last, Steve Morant, Josephine E A Parker, John Pickett, Billy J Quilty, Ann Rooney, Manil Shah, Mark Somerville, Chelci Squires, Martin Walker, James G Logan, COVID Dogs Research Team, Robert Jones, Ana Assis, Ewan Borthwick, Laura Caton, Rachel Edwards, Janette Heal, David Hill, Nazifa Jahan, Cecelia Johnson, Angela Kaye, Emily Kirkpatrick, Sarah Kisha, Zaena Ledeatte Williams, Robert Moar, Tolulope Owonibi, Benjamin Purcell, Christopher Rixson, Freya Spencer, Anastasios Stefanidis, Sophie Stewart, Scott Tytheridge, Sian Wakley, Shanice Wildman, Catherine Aziz, Helen Care, Emily Curtis, Claire Dowse, Alan Makepeace, Sally-Anne Oultram, Jayde Smith, Fiona Shenton, Harry Hutchins, Robert Mart, Jo-Anne Cartwright, Miranda Forsey, Kerry Goodsell, Lauren Kittridge, Anne Nicholson, Angelo Ramos, Joanne Ritches, Niranjan Setty, Mark Vertue, Malin Bergstrom, Zain Chaudhary, Angus De Wilton, Kate Gaskell, Catherine Houlihan, Imogen Jones, Marios Margaritis, Patricia Miralhes, Leah Owens, Tommy Rampling, Hannah Rickman, Marta Boffito, Candida Fernandez, Bryony Cotterell, Anne-Marie Guerdette, George Tsaknis, Margaret Turns, Joanne Walsh, Lisa Frankland, Raha West, Maureen Holland, Natalie Keenan, Helen Wassall, Megan Young, Jade Rangeley, Gwendolyn Saalmink, Sanjay Adlakha, Philip Buckley, Lynne Allsop, Susan Smith, Donna Sowter, Alison Campbell, Julie Jones, Steve Laird, Sarah O'Toole, Courteney Ryan, Jessica Evans, James Rand, Natasha Schumacher, Tracey Hazelton, Andrew Dodgson, Susannah Glasgow, Denise Kadiu, Orianne Lopuszansky, Anu Oommen, Joshi Prabhu, Molly Pursell, Jane Turner, Hollie Walton, Robert Andrews, Irena Cruickshank, Catherine Thompson, Tania Wainwright, Alun Roebuck, Tara Lawrence, Kimberley Netherton, Claire Hewitt, Sarah Shephardson, Winston Andrew Crasto, Judith Lake, Rosemary Musanhu, Rebecca Walker, Karen Burns, Andrew Higham, Julie Le Bas, Nicola Mackenzie, Hilary Thatcher, Shannen Beadle, Sarah Buckley, Gail Castle, Aimee Fletcher, Sara Holbrook, Patricia Kane, Kate Lindley, Tracey Lowry, Stephanie Lupton, Sharon Oddy, Lynda Slater, Martin Sylvester, Kenneth Agwuh, Veronica Maxwell, Stephen Ryder, Kirsty Topham, Obi Egbuniwe, Rebecca Matthews, Alejandro Arenas-Pinto, Paulina Prymas, Abigail Severn, Amber Shaw, Safia Begum, Daniel Lenton, James Scriven, Lucy Leeman, Karen Rudge, Emma Storr, Ana Alvarez, Kate Forster, Daniel Hind, Natalie Cook, Rosanna Peeling, Peter Carey, Anne Wilson, Jane Davis

Abstract

Background: A rapid, accurate, non-invasive diagnostic screen is needed to identify people with SARS-CoV-2 infection. We investigated whether organic semi-conducting (OSC) sensors and trained dogs could distinguish between people infected with asymptomatic or mild symptoms, and uninfected individuals, and the impact of screening at ports-of-entry.

Methods: Odour samples were collected from adults, and SARS-CoV-2 infection status confirmed using RT-PCR. OSC sensors captured the volatile organic compound (VOC) profile of odour samples. Trained dogs were tested in a double-blind trial to determine their ability to detect differences in VOCs between infected and uninfected individuals, with sensitivity and specificity as the primary outcome. Mathematical modelling was used to investigate the impact of bio-detection dogs for screening.

Results: About, 3921 adults were enrolled in the study and odour samples collected from 1097 SARS-CoV-2 infected and 2031 uninfected individuals. OSC sensors were able to distinguish between SARS-CoV-2 infected individuals and uninfected, with sensitivity from 98% (95% CI 95-100) to 100% and specificity from 99% (95% CI 97-100) to 100%. Six dogs were able to distinguish between samples with sensitivity ranging from 82% (95% CI 76-87) to 94% (95% CI 89-98) and specificity ranging from 76% (95% CI 70-82) to 92% (95% CI 88-96). Mathematical modelling suggests that dog screening plus a confirmatory PCR test could detect up to 89% of SARS-CoV-2 infections, averting up to 2.2 times as much transmission compared to isolation of symptomatic individuals only.

Conclusions: People infected with SARS-CoV-2, with asymptomatic or mild symptoms, have a distinct odour that can be identified by sensors and trained dogs with a high degree of accuracy. Odour-based diagnostics using sensors and/or dogs may prove a rapid and effective tool for screening large numbers of people.Trial Registration NCT04509713 (clinicaltrials.gov).

Keywords: COVID-19; infection control; public health; rapid screening.

© The Author(s) 2022. Published by Oxford University Press on behalf of International Society of Travel Medicine.

Figures

Figure 1
Figure 1
Principal component analysis of odour samples by organic semi-conducting (OSC) sensors on two different days; (A) Day 1 and (B) Day 2. Where red circles SARS-CoV-2 infected samples and green triangles are SARS-CoV-2 uninfected odour samples
Figure 2
Figure 2
Modelling the effectiveness of a Rapid Screen and Test strategy. The Ct-dependent sensitivity was estimated by fitting a logistic regression model to the results of the double-blind testing (this study) for dogs and to the data presented for the lateral flow test (LFT) in Peto. Results show that sensitivity is independent of Ct for dogs (panel A; P = 0.570) whereas sensitivity decreases with increasing Ct values for LFT (panel B; P < 0.0001). The cycle threshold (Ct) is considered a proxy for viral load and is repeatedly simulated from a distribution defined by a starting Ct, a peak Ct and a total duration of infection with a random time since initial exposure. Panel C shows the relationship between Ct and time since exposure for a typical symptomatic individual (asymptomatic individuals having 40% shorter duration of infection). Inset panel shows that both symptomatic and asymptomatic individuals have Ct values between 35 and 40 for approximately one third of the duration of infection. The modelled relationship between sensitivity and Ct for PCR, LFT and dogs is shown in panel D. The sensitivity-Ct relationship for dogs (light green line, 80%; green line, 85%; dark green line, 90%) and LFT (orange line) was informed from data as shown in panels (A) and (B). The sensitivity for PCR was assumed to be 100% up to a Ct of 35, either remaining at this level to a Ct of 40 (yellow solid line) or declining to 0% between 35 and 40 (yellow dotted line). This uncertainty of sensitivity between Ct values of 35 and 40 was also considered for the dogs, with different sensitivity estimated from the data of the double-blind testing (green dotted lines) and representing variability in dog performance. The percentage of cases detected by different strategies is shown in panel E, where baseline corresponds to isolation of symptomatic individuals only and PCR corresponds to the (hypothetical) screening of all individuals with PCR. LFT + PCR and Dogs + PCR indicate, respectively, rapid mass screening with LFTs or dogs followed by confirmatory PCR of positively identified cases. The ratio of the transmission averted by these scenarios compared to baseline is shown in panel F. In panels E and F, filled and open points correspond to a Ct detection limit of 35 and 40 respectively
Figure 3
Figure 3
Exemplar of (A) Current SARS-CoV-2 Strategy for red list countries and unvaccinated travellers (10-day quarantine and PCR tests) and (B) Proposed Rapid Screen and Test Strategy. Schematic outlining the number of true negatives (black) and true positives (red) and false negatives (blue) as a result of screening people, with 1% SARS-CoV-2 prevalence, followed by confirmatory PCR testing. Assuming 100% sensitivity and specificity of RT-PCR, and 90% sensitivity and 89% specificity of dogs (values used in the mathematical modelling). ‘Inconvenienced’ refers to virus-negative passengers required to be in quarantine (red dotted line)

References

    1. Hafeez S, Din M, Zia F et al. Emerging concerns regarding COVID-19; second wave and new variant. J Med Virol 2021; 93:4108–4110.
    1. Mahase E. Covid-19: what new variants are emerging and how are they being investigated? BMJ 2021; 372:n158.
    1. Gostic K, Gomez ACR, Mummah RO et al. Estimated effectiveness of symptom and risk screening to prevent the spread of COVID-19. Elife 2020; 9:e55570.
    1. Mina MJ, Peto TE, García-Fiñana M et al. Clarifying the evidence on SARS-CoV-2 antigen rapid tests in public health responses to COVID-19. Lancet 2021; 397:1425–7.
    1. Lee LYW, Rozmanowski S, Pang M et al. SARS-CoV-2 infectivity by viral load, S gene variants and demographic factors and the utility of lateral flow devices to prevent transmission. Clin Infect Dis 2021; 74:407–415.
    1. Pickering S, Batra R, Snell LB et al. Comparative performance of SARS-CoV-2 lateral flow antigen tests and association with detection of infectious virus in clinical specimens: a single-centre laboratory evaluation study. Lancet Microbe 2021; 2:e461–e471.
    1. Quilty BJ, Clifford SC, Hellewell J et al. Quarantine and testing strategies in contact tracing for SARS-CoV-2: a modelling study. Lancet Public Health 2021; 6:E175–E183.
    1. El Qader AA, Lieberman D, Avni YS et al. Volatile organic compounds generated by cultures of bacteria and viruses associated with respiratory infections. Biomed Chromatogr 2015; 29:1783–90.
    1. Purcaro G, Rees CA, Wieland-Alter WF et al. Volatile fingerprinting of human respiratory viruses from cell culture. J Breath Res 2018; 12:026015–5.
    1. Schivo M, Aksenov AA, Linderholm AL et al. Volatile emanations from in vitro airway cells infected with human rhinovirus. J Breath Res 2014; 8:037110–0.
    1. Mashir A, Paschke KM, van Duin D et al. Effect of the influenza A (H1N1) live attenuated intranasal vaccine on nitric oxide (FENO) and other volatiles in exhaled breath. J Breath Res 2011; 5:037107. 10.1088/1752-7155/5/3/037107.
    1. Jones RT, Guest C, Lindsay SW et al. Could bio-detection dogs be used to limit the spread of COVID-19 by travellers? J Travel Med 2020; 27:taaa131.
    1. Ehmann R, Boedeker E, Friedrich U et al. Canine scent detection in the diagnosis of lung cancer: revisiting a puzzling phenomenon. Eur Respir J 20121; 39:669–76.
    1. Rooney NJ, Morant S, Guest C. Investigation into the value of trained glycaemia alert dogs to clients with type I diabetes. PLoS One 2013; 8:e69921.
    1. Willis CM, Church SM, Guest CM et al. Olfactory detection of human bladder cancer by dogs: proof of principle study. BMJ 2004; 329:712.
    1. Guest C, Pinder M, Doggett M. Trained dogs identify people with malaria parasites by their odour. Lancet Infect Dis 2019; 19:578–80.
    1. Walker D, Walker J, Cavnar P et al. Naturalistic quantification of canine olfactory sensitivity. Appl Anim Behav Sci 2006; 97:241–54.
    1. Vesga O, Valencia AF, Mira A et al. Dog savior: immediate scent-detection of SARS-COV-2 by trained dogs. bioRxiv 2020.06.17.158105; doi: 10.1101/2020.06.17.158105.
    1. Grandjean D, Sarkis R, Lecoq-Julien C et al. Can the detection dog alert on COVID-19 positive persons by sniffing axillary sweat samples? A proof-of-concept study. PLoS ONE 2020; 15:e0243122. .
    1. Jendrny P, Schulz C, Twele F et al. Scent dog identification of samples from COVID-19 patients–a pilot study. BMC Infect Dis 2020; 20:1–7.
    1. Jendrny P, Twele F, Meller S et al. Scent dog identification of SARS-COV-2 infections, similar across different body fluids. BMC Infect Dis 2021; 21:707.
    1. Eskandari E, Marzaleh MA, Roudgari H et al. Sniffer dogs as a screening/diagnostic tool for COVID-19: a proof of concept study. BMC Infect Dis 2021; 21:243.
    1. Granjean D, Al Marzooqi DH, Lecoq-Julien C et al. Use of canine olfactory detection for COVID-19 testing study on UAE trained detection dog sensitivity. J Vet Sci Res 2021; 6:000210.
    1. Essler JL, Kane SA, Nolan P et al. Discrimination of SARS-CoV-2 infected patient samples by detection dogs: a proof of concept study. PLoS One 2021; 16:e0250158.
    1. Ruszkiewicz DM, Sanders D, O’Brien R et al. Diagnosis of COVID-19 by analysis of breath with gas chromatography-ion mobility spectrometry—a feasibility study. EClinicalMedicine 2020; 3329-30:100609–9.
    1. Dendukuri N, Joseph L. Bayesian approaches to modeling the conditional dependence between multiple diagnostic tests. Int Biometric Soc 2001; 57:158–67.
    1. Peto T. UK COVID-19 lateral flow oversight team. COVID-19: rapid antigen detection for SARS-CoV-2 by lateral flow assay: a national systematic evaluation for mass-testing. E Clinical Medicine 2021; 36:100924.
    1. Oxford University and PHE Porton Down. University of Oxford SARS-CoV-2 test development and validation cell. Preliminary report from the Joint PHE Porton Down & University of Oxford SARS-CoV-2 test development and validation cell: Rapid evaluation of Lateral Flow Viral Antigen detection devices (LFDs) for mass community testing; 2020.
    1. Tsang NNY, So HC, Ng KY et al. Diagnostic performance of different sampling approaches for SARS-CoV-2 RT-PCR testing: a systematic review and meta-analysis. Lancet Infect Dis 2021; 21:1233–1245.

Source: PubMed

3
Sottoscrivi